OptiBiotix Health PLC (OPTI)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
6.50p
Buy
7.00p
0.00p (+0.00%)
Prices updated at 17 Dec 2025, 14:44 GMT
| Prices minimum 15 mins delay
Prices in GBX
OptiBiotix Health PLC is a life sciences company. The company through its subsidiaries is engaged in the research and development of microbiome modulators.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2024 | 38.05 |
| 2023 | 49.69 |
| 2022 | 53.39 |
| 2021 | 50.75 |
| 2020 | 57.76 |
| 2018 | 68.35 |
| 2017 | 61.43 |
| 2016 | 86.74 |
Valuation data table
Year | Price / Sales |
|---|---|
| 2025 | 6.06 |
| 2024 | 33.15 |
| 2023 | 37.63 |
| 2022 | 10.04 |
| 2021 | 24.89 |
| 2020 | 84.82 |
| 2019 | 96.51 |
| 2018 | 407.95 |
| 2017 | 183.85 |
| 2016 | 395.26 |
| 2015 | - |
Price/Forward earnings (YTD)
-
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2024 | -19.57 |
| 2023 | -19.46 |
| 2022 | 16.33 |
| 2021 | 36.99 |
| 2020 | 56.62 |
| 2018 | -24.45 |
| 2017 | 28.61 |
| 2016 | -25.87 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2024 | 1.08 |
| 2023 | 1.06 |
| 2022 | 1.06 |
| 2021 | 1.11 |
| 2020 | 1.16 |
| 2018 | 1.14 |
| 2017 | 1.09 |
| 2016 | 1.15 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
